Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	May 31, 2023	May 31, 2022
Cash Flows From Operating Activities:
Net income (loss) available to common shareholders	$ 24,922	$ 24,077
Net income (loss) from discontinued operations	0	8,724
Dividends on preferred stock	3,600	0
Net income from continuing operations	28,522	15,353
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:
Bad debt expense	18	246
Depreciation and amortization	18,524	11,973
Deferred income taxes	(2,022)	(2,340)
Equity in earnings of unconsolidated entities	(1,420)	0
Net (gain) on sale of property, plant and equipment	(2)	(29)
Amortization of debt financing costs	3,029	1,541
Share-based compensation expense	1,904	1,998
Effects of changes in assets and liabilities, net of acquisitions and dispositions:
Accounts receivable	12,936	(20,941)
Inventories	(1,198)	(10,362)
Prepaid expenses and other	(2,494)	(8,374)
Other assets	43	49
Net change in contract assets and liabilities	(1,949)	(5,885)
Accounts payable	(2,665)	37,915
Other accrued liabilities and income taxes payable	(6,333)	531
Net cash provided by operating activities of continuing operations	46,893	21,675
Cash flows from investing activities
Other investing activities	9	33
Acquisition of subsidiaries, net of cash acquired	0	(1,298,514)
Purchase of property, plant and equipment	(17,036)	(6,472)
Net cash used in investing activities of continuing operations	(17,027)	(1,304,953)
Cash flows from financing activities:
Payments for taxes related to net share settlement of equity awards	(1,710)	(2,314)
Proceeds from revolving loan	92,000	39,000
Payments on revolving loan	(112,000)	(116,000)
Proceeds from long term debt	0	1,540,000
Payments of debt financing costs	0	(87,555)
Payments of dividends	(7,835)	(4,192)
Net cash provided by (used in) financing activities of continuing operations	(29,545)	1,368,939
Effect of exchange rate changes on cash	737	(49)
Net cash used in operating activities from discontinued operations	0	1,636
Net cash used in investing activities from discontinued operations	0	(1,332)
Net cash provided by financing activities from discontinued operations	0	0
Cash used in discontinued operations	0	304
Net increase in cash and cash equivalents	1,058	85,916
Cash and cash equivalents at beginning of period	2,820	15,082
Cash and cash equivalents at end of period	3,878	100,998
Cash and cash equivalents at end of period	3,878	97,998
Less: Cash and cash equivalents from discontinued operations at end of period	0	(3,000)
Supplemental disclosures of non-cash investing and financing activities
Cash paid for interest	25,866	4,161
Cash paid for income taxes	895	4,034
Accrued dividends on Series A Preferred Stock	2,400	0
Accruals for capital expenditures	$ 2,409	$ 1,136